Relmada Therapeutics

1 Follower


Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain.

Charles S. Ence
Chief Accounting and Compliance Officer
Maged Shenouda
Chief Financial Officer
Molly Harper
EVP, Operations
Marc de Somer
SVP, Clinical Development
Marco Pappagallo
Acting Chief Medical Officer
Judy Caron
Vice President of Drug Development

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.